• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Testing for hepatitis C virus remains low among baby boomers

Bioengineer by Bioengineer
March 8, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force (USPSTF) recommended it for all baby boomers, and finds rates are still very low.

Background:

  • Approximately 3.5 million people in the United States have chronic hepatitis C virus (HCV) infection.
  • Most of those (80%) are "baby boomers" (born between 1945 and 1965), and most of them are unaware of their infections despite availability of treatments that may reduce their risk of HCV-related diseases, including chronic hepatitis, cirrhosis, and liver cancer.
  • The U.S. Preventive Services Task Force (USPSTF) recommended one-time HCV testing for baby boomers in 2013.
  • In a 2013 report, the authors noted low HCV testing prevalence among baby boomers. However, it is unknown whether HCV testing has changed following the USPSTF recommendation.

Highlights from the study:

  • Investigators studies responses from nearly 24,000 baby boomers included in the National Health Interview Survey.
  • From 2013 to 2015, HCV testing prevalence among baby boomers increased slightly, from 12.3% to 13.8%.
  • Of the 76.2 million estimated baby boomers in 2015, only 10.5 million reported ever receiving HCV testing.
  • Those with Medicare plus Medicaid, Medicaid only, or military insurance had higher rates of HCV testing than the privately insured.
  • HCV testing was also greater in men versus women, and among college graduates

"Prevalence of HCV testing among baby boomers did not substantially increase and remains low two years after the USPSTF recommendation in 2013," write the authors. "These findings underscore the need for increased awareness for HCV testing among healthcare providers and baby boomers and other innovative strategies such as state-mandated HCV testing."

###

Article: Recent Hepatitis C Virus Testing Patterns Among Baby Boomers; Am J Prevent Med 10.1016/j.amepre.2017.01.033

Media Contact

David Sampson
[email protected]
@ACSNews

http://www.cancer.org

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

CoMn2O4-rGO Nanocomposite Enhances Supercapacitor Performance

November 3, 2025
blank

Perpendicular-Anisotropy Spin Ice Enables Tunable Reservoir Computing

November 3, 2025

Nutrient Sources’ Influence on Gladiolus Growth and Soil Microbes

November 3, 2025

Vitamin D’s Impact on Autism: A Clinical Trial

November 3, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1296 shares
    Share 518 Tweet 324
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    204 shares
    Share 82 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    137 shares
    Share 55 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

CoMn2O4-rGO Nanocomposite Enhances Supercapacitor Performance

Perpendicular-Anisotropy Spin Ice Enables Tunable Reservoir Computing

Nutrient Sources’ Influence on Gladiolus Growth and Soil Microbes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.